Lee D Ying1,2, Gregory A Breuer1, Matthew O Hubbard1,3, Geoffrey S Nadzam1,3, John Hwa1,2, Kathleen A Martin4,5. 1. Yale University School of Medicine, New Haven, CT, 06511, USA. 2. Yale Cardiovascular Research Center, 300 George St, Room 759, New Haven, CT, 06511, USA. 3. Department of Gastrointestinal Surgery, Yale New Haven Health, New Haven, CT, 06511, USA. 4. Yale University School of Medicine, New Haven, CT, 06511, USA. Kathleen.martin@yale.edu. 5. Yale Cardiovascular Research Center, 300 George St, Room 759, New Haven, CT, 06511, USA. Kathleen.martin@yale.edu.
Abstract
BACKGROUND: Sleeve gastrectomy with ileal transposition has been shown to be superior to sleeve gastrectomy alone for promoting weight loss in rat and porcine models. The absence of a mouse model for this procedure has impeded efforts to understand the molecular physiology underlying its efficacy. This study demonstrates the long-term survivability of sleeve gastrectomy with ileal transposition in mice. MATERIALS AND METHODS: In this study of technical feasibility, a sleeve gastrectomy with ileal transposition (SGIT), sleeve gastrectomy (SG), or sham surgery (SH) was performed on 7- to 8-week-old C57Bl/6J mice (n = 8 for each). To evaluate long-term survivability, mice were placed on an obesogenic diet and weighed weekly for 10 weeks. The intestinal identity of the transposed segment was assessed with gene expression analysis of duodenal-, jejunal-, and ileal-specific hormones using quantitative polymerase chain reaction. RESULTS: Overall, SGIT better prevented weight gain than the SG or sham procedures (10-week post-operative weight: SH 45.3 ± 1.0 g, SG 41.25 ± 1.6 g, SGIT 35.4 ± 0.8 g). Gene expression pattern analysis of three markers of intestinal identity (gastrin, cholecystokinin, and peptide YY) suggests that the ileal identity of the transposed segment is maintained 10 weeks after transposition. CONCLUSIONS: We demonstrate for the first time a reproducible mouse model of sleeve gastrectomy with ileal transposition. Future studies utilizing this model will expand our understanding of the molecular pathways through which the hindgut regulates satiety.
BACKGROUND: Sleeve gastrectomy with ileal transposition has been shown to be superior to sleeve gastrectomy alone for promoting weight loss in rat and porcine models. The absence of a mouse model for this procedure has impeded efforts to understand the molecular physiology underlying its efficacy. This study demonstrates the long-term survivability of sleeve gastrectomy with ileal transposition in mice. MATERIALS AND METHODS: In this study of technical feasibility, a sleeve gastrectomy with ileal transposition (SGIT), sleeve gastrectomy (SG), or sham surgery (SH) was performed on 7- to 8-week-old C57Bl/6J mice (n = 8 for each). To evaluate long-term survivability, mice were placed on an obesogenic diet and weighed weekly for 10 weeks. The intestinal identity of the transposed segment was assessed with gene expression analysis of duodenal-, jejunal-, and ileal-specific hormones using quantitative polymerase chain reaction. RESULTS: Overall, SGIT better prevented weight gain than the SG or sham procedures (10-week post-operative weight: SH 45.3 ± 1.0 g, SG 41.25 ± 1.6 g, SGIT 35.4 ± 0.8 g). Gene expression pattern analysis of three markers of intestinal identity (gastrin, cholecystokinin, and peptide YY) suggests that the ileal identity of the transposed segment is maintained 10 weeks after transposition. CONCLUSIONS: We demonstrate for the first time a reproducible mouse model of sleeve gastrectomy with ileal transposition. Future studies utilizing this model will expand our understanding of the molecular pathways through which the hindgut regulates satiety.
Entities:
Keywords:
Mouse metabolic surgery; Sleeve gastrectomy with ileal transposition
Authors: Aureo L de Paula; Antônio L V Macedo; Alcyr S Prudente; Luiz Queiroz; Vladimir Schraibman; Jaques Pinus Journal: Surg Obes Relat Dis Date: 2006 Jul-Aug Impact factor: 4.734
Authors: Elizabeth M Nesset; Michael L Kendrick; Scott G Houghton; Jane L Mai; Geoffrey B Thompson; Florencia G Que; Kristine M Thomsen; Dirk R Larson; Michael G Sarr Journal: Surg Obes Relat Dis Date: 2007 Jan-Feb Impact factor: 4.734
Authors: F Seyfried; M Lannoo; W Gsell; J L Tremoleda; M Bueter; T Olbers; C Jurowich; C-T Germer; C W le Roux Journal: Obes Surg Date: 2012-07 Impact factor: 4.129
Authors: Patrick Noel; Anne-Sophie Schneck; Marius Nedelcu; Ji-Wann Lee; Jean Gugenheim; Michel Gagner; Antonio Iannelli Journal: Surg Obes Relat Dis Date: 2014-03-15 Impact factor: 4.734
Authors: W J Pories; M S Swanson; K G MacDonald; S B Long; P G Morris; B M Brown; H A Barakat; R A deRamon; G Israel; J M Dolezal Journal: Ann Surg Date: 1995-09 Impact factor: 12.969
Authors: Josh W Pressler; April Haller; Joyce Sorrell; Fei Wang; Randy J Seeley; Patrick Tso; Darleen A Sandoval Journal: Diabetes Date: 2014-08-25 Impact factor: 9.461